Potential Cases to be Selected for Second Mirena IUD Trial

Potential Cases to be Selected for Second Mirena IUD Trial

Potential Cases to be Selected for Second Mirena IUD Trial


A recent court order has directed the parties to select seven cases that may be included in the second Mirena intrauterine device (IUD) trial.

According to a court order filed on March 17, 2015, each side must select seven cases for potential inclusion in the Second Disposition Pool. The case is In Re: Mirena Litigation, Case No. 297 in the Superior Court of New Jersey Law Division: Bergen County. Raymond C. Silverman, partner at Parker Waichman LLP, has been appointed co-lead counsel in the litigation.

For cases to be considered eligible, the core criteria in the plaintiff fact sheet must be completed by May 1, 2015, according to the order. The selections must be reported to the court by email, by 4:00 p.m. Eastern Time on July 2, 2015. The court order indicates that the cases selected should not have unique or idiosyncratic circumstances.

The Mirena litigation represents a number of women who were allegedly injured by the Mirena IUD. The small, t-shaped contraceptive device works by releasing a daily dose of the hormone progestin levonorgestrel. But when the device does not remain properly in place, it can cause serious complications for the user, including pain, infection, and organ damage. According to reports made to the Food and Drug Administration (FDA), in some cases, the device became embedded in the uterine wall or even migrated outside of the uterus into the abdominal cavity.

“We are pleased to see the litigation moving forward and are delighted that we are one day closer to ensuring justice for those women who have alleged suffering serious, life-changing injuries as a result of the Mirena system,” said Matthew J. McCauley, Senior Litigation Counsel at Parker Waichman LLP.

 

 

This entry was posted in Defective Medical Devices, Mirena IUD and tagged , , , , . Bookmark the permalink.


© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.